Clinical Trial Update: The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, multicenter trial sponsored by JSC NextGen evaluating a treatment for diabetic foot ulcers in diabetes mellitus; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer

Snippet

Sponsor: JSC NextGen | Conditions: Ulcer Foot, Mellitus Diabetes | Phase 3 | Status: RECRUITING